DOCSLIB.ORG

Cr75th Anniversary Commentary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cr75th Anniversary Commentary CR 75th Anniversary Commentary Review Article Commentary on Folkman: "How Is Blood Vessel Growth Regulated in Normal and Neoplastic Tissue?" Hellmut G. Augustin1,2,3 Abstract Angiogenesis is a prerequisite for tumor growth and met- Lecture delivered by Dr. Judah Folkman. Thirty years later, astatic progression. The discovery of the first specificangio- this award lecture is a lively testimony of the visionary mind genic cytokine, VEGF, in 1989 paved the way for the clinical of Dr. Folkman, whose legacy continues to inspire contem- approval of the first antiangiogenic tumor drug 15 years porary angiogenesis research. Cancer Res; 76(10); 2854–6. Ó2016 later. This brief commentary highlights and puts into his- AACR. torical perspective the 1985 G.H.A. Clowes Memorial Award See related article by Folkman J, Cancer Res 1986;46:467-73. Dr. Judah Folkman of Children's Hospital at Harvard Medical these predictions have become a reality, but the field of angio- School (Boston, MA) was the 25th recipient of the American genesis research was still in its infancy when Dr. Folkman deliv- Association for Cancer Research (AACR) G.H.A. Clowes Memorial ered the Clowes lecture 14 years later (less than 100 angiogenesis- Award. This award recognizes outstanding accomplishments related articles were published in 1985 compared with almost in basic cancer research and comes with the honor to deliver an 7,000 per year today). He outlined in his lecture in some detail the award lecture at the annual AACR meeting. Folkman delivered steps of the angiogenic cascade with endothelial cells in post- the award lecture during the 76th Annual Meeting of the AACR in capillary venules degrading their surrounding extracellular matrix Houston, TX, on May 24, 1985. An edited version of his lecture and migrating toward the angiogenic stimulus to only subse- was published in the February 1986 issue of Cancer Research (1). quently proliferate. Outgrowing capillary sprouts eventually anas- The awardee summarized in this lecture 25 years of pioneering tomose to form new capillary loops and networks. research through which his laboratory had essentially single The 1980s were an intense period of hunting for the ominously handedly established the field of angiogenesis research by estab- hypothesized tumor angiogenesis factor (TAF; ref. 5). Shing, lishing techniques for the culture of endothelial cells (2), devel- Folkman, and Klagsbrun had just reported the heparin affinity oping relevant animal models (3), and purifying the first angio- of many growth factors (6). This provided a unique tool to genic growth factor (4). identify growth factors by heparin-affinity chromatography. On the basis of the experiments in isolated perfused organs, Dr. Many new growth factors were identified at the time, including Folkman had published a hypothesis article in the New England the fibroblast growth factor. Some of these were potent endothe- Journal of Medicine in 1971 (i) predicting that tumors would be lial mitogens capable of inducing angiogenesis in cellular settings restricted to microscopic size in the absence of angiogenesis, (ii) and in vivo, yet all factors identified in the mid-1980s turned out to suggesting that tumors secrete diffusible angiogenic molecules, be pleiotropic factors with multiple biologic functions limiting (iii) describing a model of tumor dormancy due to blocked their usefulness as therapeutic targets. angiogenesis, (iv) proposing the term antiangiogenesis for the Dr. Folkman also described in his lecture early attempts to prevention of new capillary sprouts from being recruited into a develop antiangiogenic compounds. Combinations of heparin growing tumor, (v) envisaging the future discovery of angiogen- with different formulations of mineralocorticoids or glucocorti- esis inhibitors, and (vi) proposing the idea that an antibody to a coids were reported to exert potent antiangiogenic activity in tumor angiogenic factor could be an anticancer drug (5). All of cellular assays and tumor angiogenesis experiments. Most of this early angiogenesis inhibitor work did not stand the test of time, but it paved the way for the subsequent identification of specific 1 Division of Vascular Oncology and Metastasis (DKFZ-ZMBH Alliance), angiogenic factors and corresponding inhibitors. German Cancer Research Center, Heidelberg, Germany. 2Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty As early as 1983, Don Senger and Harold Dvorak of Beth Israel Mannheim, Heidelberg University, Heidelberg, Germany. 3German Hospital at Harvard Medical School had reported the isolation of Cancer Consortium, Heidelberg, Germany. a tumor-derived factor that potently stimulates vascular perme- Corresponding Author: Hellmut G. Augustin, Medical Faculty Mannheim ability, called the vascular permeability factor (VPF; ref. 7), yet this (CBTM), Heidelberg University, and German Cancer Research Center Heidelberg discovery was left largely unnoticed and the article was in the first (DKFZ-ZMBH Alliance), Im Neuenheimer Feld 280, Heidelberg D-69221, 5 years after its publication cited only 45 times (citations until Germany. Phone: 4962-2142-1500; Fax: 4962-2142-1515; E-mail: April 2016: 2,600 times). This changed only when Napoleone [email protected] Ferrara of Genentech published the discovery of the first endo- doi: 10.1158/0008-5472.CAN-16-1123 thelial cell–specific growth factor in 1989 that he called VEGF (so Ó2016 American Association for Cancer Research. far, 3,700 citations; ref. 8), which turned out to be identical to 2854 Cancer Res; 76(10) May 15, 2016 Downloaded from cancerres.aacrjournals.org on September 23, 2021. © 2016 American Association for Cancer Research. Regulation of Blood Vessel Growth VPF. This landmark discovery was made around the same time of clinical implementation, the objectives and the mechanism- by Folkman's laboratory and published jointly with Ferrara of-action of antiangiogenic intervention in human tumor only 7 months later (9). The discovery of VEGF as the first specific patients are less clear than ever. Both vascular regression (as angiogenesis factor set in motion the revolution in the field postulated by Folkman) as well as vascular normalization (i.e., of angiogenesis research, with the most dramatic growth in pruning of the most immature intratumoral vessels to leave the 1990s, that has resulted, 15 years after the discovery of behind a more normal appearing and thereby chemotherapy- VEGF, in the clinical approval of the first angiogenesis inhibitor, facilitating vasculature) contribute to antiangiogenic therapy, the VEGF-neutralizing antibody bevacizumab, for the treat- yet the contribution of these two processes, regression and ment of metastatic colorectal cancers (more than 6,000 citations normalization, in different types of human tumors is not at so far; ref. 10). all understood. Moreover, little is known about the temporal Folkman knew at the time of the award lecture that the "real" effects of antiangiogenic intervention. All these limitations angiogenic factors had not yet been discovered. He stated in the severely contribute to the difficulties in the rational and mech- concluding remarks: "In my more grandiose moments, I think anism-based advancement of antiangiogenesis. of a day to come when it may be possible to use angiogenesis Ad ii: VEGF comes close to the magic TAF postulated by inhibitors as an adjunct to conventional therapy." He also Folkman. VEGF stands up high in the hierarchy of events that wrote: "Hopefully, we may eventually learn enough about the leads to the growth of new blood vessels, yet VEGF is not the angiogenic process so that other diseases dominated by abnor- only specific angiogenesis factor. Combinations with factors mal angiogenesis, e.g., many types of ocular neovasculariza- controlling later steps of the angiogenic cascade are in advanced tion, might be brought under control." Both of these statements clinical development. For oncology, combinations of anti- are a most remarkable reflection of Folkman's visionary mind. VEGF/VEGFR with anti-angiopoietin-2 are most advanced in Folkman had envisioned antiangiogenesis as an adjunct to clinical development. For ophthalmology, the combination of conventional therapy, not as replacing it. When antiangiogenic anti-VEGF with anti-PDGFRb is in phase III clinical trials. tumor monotherapy turned out to be ineffective at the begin- Future developments in the fieldalsoholdgreatpromisethat ning of the millennium, the field of antiangiogenesis research antiangiogenic drugs contribute to remodeling the tumor almost collapsed. It was not until 2003 when the combination microenvironment in a way that they do not just facilitate of antiangiogenesis and chemotherapy proved to be more chemotherapy, but that they may also be key to improving effective than chemotherapy alone. The addition of an anti- the efficacy of tumor-curing immunotherapies. angiogenic drug extended median overall survival by 25% The legacy of Judah Folkman is still very much alive. His (from 15.6 to 20.3 months) in a phase III colorectal cancer brilliant mind has left the community with a plethora of still study involving more than 800 patients (10). The second unanswered questions: What are the biologic consequences of statementofFolkmanturnedouttobesimilarlyvisionary: angiogenesis stimulators being short-lived and locally acting, antiangiogenesis has become part of standard first-line tumor whereas the angiogenesis inhibitors supposedly are long-lived therapy, yet its efficacy is to this day rather limited,
Load more

Recommended publications
  • Molecular Signatures of Tissue-Specific
    Developmental Cell Resource Molecular Signatures of Tissue-Specific Microvascular Endothelial Cell Heterogeneity in Organ Maintenance and Regeneration Daniel J. Nolan,1,6 Michael Ginsberg,1,6 Edo Israely,1 Brisa Palikuqi,1 Michael G. Poulos,1 Daylon James,1 Bi-Sen Ding,1 William Schachterle,1 Ying Liu,1 Zev Rosenwaks,2 Jason M. Butler,1 Jenny Xiang,4 Arash Rafii,1,7 Koji Shido,1 Sina Y. Rabbany,1,8 Olivier Elemento,3 and Shahin Rafii1,5,* 1Department of Genetic Medicine, Howard Hughes Medical Institute 2Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine 3HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine 4Genomics Resource Core Facility Weill Cornell Medical College, New York, NY 10065, USA 5Ansary Stem Cell Institute, New York, NY 10065, USA 6Angiocrine Bioscience, New York, NY 10065, USA 7Weill Cornell Medical College-Qatar, Stem Cell and Microenvironment Laboratory, Education City, Qatar Foundation, Doha 24144, Qatar 8Bioengineering Program, Hofstra University, Hempstead, NY 11549, USA *Correspondence: srafi[email protected] http://dx.doi.org/10.1016/j.devcel.2013.06.017 SUMMARY been appreciated. Capillary ECs of the blood brain barrier (BBB) form a restrictive environment for passage between the Microvascular endothelial cells (ECs) within different brain tissue and the circulating blood. Many of the trafficking pro- tissues are endowed with distinct but as yet unrecog- cesses that are passive in other vascular beds are tightly nized structural, phenotypic, and functional attri- controlled in the brain (Rubin and Staddon, 1999). As opposed butes. We devised EC purification, cultivation, to the BBB, the capillary ECs of the kidney glomeruli are fenes- profiling, and transplantation models that establish trated for the filtration of the blood (Churg and Grishman, tissue-specific molecular libraries of ECs devoid of 1975).
    [Show full text]
  • Terminology Resource File
    Terminology Resource File Version 2 July 2012 1 Terminology Resource File This resource file has been compiled and designed by the Northern Assistant Transfusion Practitioner group which was formed in 2008 and who later identified the need for such a file. This resource file is aimed at Assistant Transfusion Practitioners to help them understand the medical terminology and its relevance which they may encounter in the patient’s medical and nursing notes. The resource file will not include all medical complaints or illnesses but will incorporate those which will need to be considered and appreciated if a blood component was to be administered. The authors have taken great care to ensure that the information contained in this document is accurate and up to date. Authors: Jackie Cawthray Carron Fogg Julia Llewellyn Gillian McAnaney Lorna Panter Marsha Whittam Edited by: Denise Watson Document administrator: Janice Robertson ACKNOWLEDGMENTS We would like to acknowledge the following people for providing their valuable feedback on this first edition: Tony Davies Transfusion Liaison Practitioner Rose Gill Transfusion Practitioner Marie Green Transfusion Practitioner Tina Ivel Transfusion Practitioner Terry Perry Transfusion Specialist Janet Ryan Transfusion Practitioner Dr. Hazel Tinegate Consultant Haematologist Reviewed July 2012 Next review due July 2013 Version 2 July 2012 2 Contents Page no. Abbreviation list 6 Abdominal Aortic Aneurysm (AAA) 7 Acidosis 7 Activated Partial Thromboplastin Time (APTT) 7 Acquired Immune Deficiency Syndrome
    [Show full text]
  • Lymphatic Tissue Engineering and Regeneration Laura Alderfer1, Alicia Wei1 and Donny Hanjaya-Putra1,2,3,4,5,6*
    Alderfer et al. Journal of Biological Engineering (2018) 12:32 https://doi.org/10.1186/s13036-018-0122-7 REVIEW Open Access Lymphatic Tissue Engineering and Regeneration Laura Alderfer1, Alicia Wei1 and Donny Hanjaya-Putra1,2,3,4,5,6* Abstract The lymphatic system is a major circulatory system within the body, responsible for the transport of interstitial fluid, waste products, immune cells, and proteins. Compared to other physiological systems, the molecular mechanisms and underlying disease pathology largely remain to be understood which has hindered advancements in therapeutic options for lymphatic disorders. Dysfunction of the lymphatic system is associated with a wide range of disease phenotypes and has also been speculated as a route to rescue healthy phenotypes in areas including cardiovascular disease, metabolic syndrome, and neurological conditions. This review will discuss lymphatic system functions and structure, cell sources for regenerating lymphatic vessels, current approaches for engineering lymphatic vessels, and specific therapeutic areas that would benefit from advances in lymphatic tissue engineering and regeneration. Keywords: Lymphangiogenesis, Tissue Engineering, Disease Modeling, Wound Healing, Lymphedema, Stem Cells, Biomaterials, Interstitial Fluid, Regeneration I. Introduction to the Lymphatic System and its role Interstitial fluid (IF) is a plasma filtrate that is generated Function by transcapillary filtration and is governed by Starling The lymphatic system is nearly ubiquitous in the human forces, the net difference between hydrostatic and body, present in all tissues except the epidermis, cartil- osmotic pressures, at the microcirculatory level [9]. In age, eye lens, cornea, retina, and bone marrow [1, 2]. order to maintain fluid homeostasis, lymph formation in The main functions of the lymphatic system include the initial lymphatic vessels must be balanced by the net fluid homeostasis and interstitial fluid drainage, immune flux of plasma being filtered out [4].
    [Show full text]
  • Nomina Histologica Veterinaria, First Edition
    NOMINA HISTOLOGICA VETERINARIA Submitted by the International Committee on Veterinary Histological Nomenclature (ICVHN) to the World Association of Veterinary Anatomists Published on the website of the World Association of Veterinary Anatomists www.wava-amav.org 2017 CONTENTS Introduction i Principles of term construction in N.H.V. iii Cytologia – Cytology 1 Textus epithelialis – Epithelial tissue 10 Textus connectivus – Connective tissue 13 Sanguis et Lympha – Blood and Lymph 17 Textus muscularis – Muscle tissue 19 Textus nervosus – Nerve tissue 20 Splanchnologia – Viscera 23 Systema digestorium – Digestive system 24 Systema respiratorium – Respiratory system 32 Systema urinarium – Urinary system 35 Organa genitalia masculina – Male genital system 38 Organa genitalia feminina – Female genital system 42 Systema endocrinum – Endocrine system 45 Systema cardiovasculare et lymphaticum [Angiologia] – Cardiovascular and lymphatic system 47 Systema nervosum – Nervous system 52 Receptores sensorii et Organa sensuum – Sensory receptors and Sense organs 58 Integumentum – Integument 64 INTRODUCTION The preparations leading to the publication of the present first edition of the Nomina Histologica Veterinaria has a long history spanning more than 50 years. Under the auspices of the World Association of Veterinary Anatomists (W.A.V.A.), the International Committee on Veterinary Anatomical Nomenclature (I.C.V.A.N.) appointed in Giessen, 1965, a Subcommittee on Histology and Embryology which started a working relation with the Subcommittee on Histology of the former International Anatomical Nomenclature Committee. In Mexico City, 1971, this Subcommittee presented a document entitled Nomina Histologica Veterinaria: A Working Draft as a basis for the continued work of the newly-appointed Subcommittee on Histological Nomenclature. This resulted in the editing of the Nomina Histologica Veterinaria: A Working Draft II (Toulouse, 1974), followed by preparations for publication of a Nomina Histologica Veterinaria.
    [Show full text]
  • Lymph and Lymphatic Vessels
    Cardiovascular System LYMPH AND LYMPHATIC VESSELS Venous system Arterial system Large veins Heart (capacitance vessels) Elastic arteries Large (conducting lymphatic vessels) vessels Lymph node Muscular arteries (distributing Lymphatic vessels) system Small veins (capacitance Arteriovenous vessels) anastomosis Lymphatic Sinusoid capillary Arterioles (resistance vessels) Postcapillary Terminal arteriole venule Metarteriole Thoroughfare Capillaries Precapillary sphincter channel (exchange vessels) Copyright © 2010 Pearson Education, Inc. Figure 19.2 Regional Internal jugular vein lymph nodes: Cervical nodes Entrance of right lymphatic duct into vein Entrance of thoracic duct into vein Axillary nodes Thoracic duct Cisterna chyli Aorta Inguinal nodes Lymphatic collecting vessels Drained by the right lymphatic duct Drained by the thoracic duct (a) General distribution of lymphatic collecting vessels and regional lymph nodes. Figure 20.2a Lymphatic System Outflow of fluid slightly exceeds return Consists of three parts 1. A network of lymphatic vessels carrying lymph 1. Transports fluid back to CV system 2. Lymph nodes 1. Filter the fluid within the vessels 3. Lymphoid organs 1. Participate in disease prevention Lymphatic System Functions 1. Returns interstitial fluid and leaked plasma proteins back to the blood 2. Disease surveillance 3. Lipid transport from intestine via lacteals Venous system Arterial system Heart Lymphatic system: Lymph duct Lymph trunk Lymph node Lymphatic collecting vessels, with valves Tissue fluid Blood Lymphatic capillaries Tissue cell capillary Blood Lymphatic capillaries capillaries (a) Structural relationship between a capillary bed of the blood vascular system and lymphatic capillaries. Filaments anchored to connective tissue Endothelial cell Flaplike minivalve Fibroblast in loose connective tissue (b) Lymphatic capillaries are blind-ended tubes in which adjacent endothelial cells overlap each other, forming flaplike minivalves.
    [Show full text]
  • Introduction to Capillary Electrophoresis
    Contents About this handbook..................................................................................... ii Acronyms and symbols used ....................................................................... iii Capillary electrophoresis ...............................................................................1 Electrophoresis terminology ..........................................................................3 Electroosmosis ...............................................................................................4 Flow dynamics, efficiency, and resolution ....................................................6 Capillary diameter and Joule heating ............................................................9 Effects of voltage and temperature ..............................................................11 Modes of capillary electrophoresis ..............................................................12 Capillary zone electrophoresis ..........................................................12 Isoelectric focusing ...........................................................................18 Capillary gel electrophoresis ............................................................21 Isotachophoresis ...............................................................................26 Micellar electrokinetic capillary chromatography ............................28 Selecting the mode of electrophoresis .........................................................36 Approaches to methods development by CZE and MECC .........................37
    [Show full text]
  • Blood Vessels and Circulation
    19 Blood Vessels and Circulation Lecture Presentation by Lori Garrett © 2018 Pearson Education, Inc. Section 1: Functional Anatomy of Blood Vessels Learning Outcomes 19.1 Distinguish between the pulmonary and systemic circuits, and identify afferent and efferent blood vessels. 19.2 Distinguish among the types of blood vessels on the basis of their structure and function. 19.3 Describe the structures of capillaries and their functions in the exchange of dissolved materials between blood and interstitial fluid. 19.4 Describe the venous system, and indicate the distribution of blood within the cardiovascular system. © 2018 Pearson Education, Inc. Module 19.1: The heart pumps blood, in sequence, through the arteries, capillaries, and veins of the pulmonary and systemic circuits Blood vessels . Blood vessels conduct blood between the heart and peripheral tissues . Arteries (carry blood away from the heart) • Also called efferent vessels . Veins (carry blood to the heart) • Also called afferent vessels . Capillaries (exchange substances between blood and tissues) • Interconnect smallest arteries and smallest veins © 2018 Pearson Education, Inc. Module 19.1: Blood vessels and circuits Two circuits 1. Pulmonary circuit • To and from gas exchange surfaces in the lungs 2. Systemic circuit • To and from rest of body © 2018 Pearson Education, Inc. Module 19.1: Blood vessels and circuits Circulation pathway through circuits 1. Right atrium (entry chamber) • Collects blood from systemic circuit • To right ventricle to pulmonary circuit 2. Pulmonary circuit • Pulmonary arteries to pulmonary capillaries to pulmonary veins © 2018 Pearson Education, Inc. Module 19.1: Blood vessels and circuits Circulation pathway through circuits (continued) 3. Left atrium • Receives blood from pulmonary circuit • To left ventricle to systemic circuit 4.
    [Show full text]
  • Pericytes in Microvessels: from “Mural” Function to Brain and Retina Regeneration
    International Journal of Molecular Sciences Review Pericytes in Microvessels: From “Mural” Function to Brain and Retina Regeneration 1, 2, 2 3 Nunzia Caporarello y, Floriana D’Angeli y, Maria Teresa Cambria , Saverio Candido , Cesarina Giallongo 4, Mario Salmeri 5, Cinzia Lombardo 5, Anna Longo 2, Giovanni Giurdanella 2, Carmelina Daniela Anfuso 2,* and Gabriella Lupo 2,* 1 Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA; [email protected] 2 Section of Medical Biochemistry, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy; fl[email protected] (F.D.); [email protected] (M.T.C.); [email protected] (A.L.); [email protected] (G.G.) 3 Section of General and Clinical Pathology and Oncology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy; [email protected] 4 Section of Haematology, Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy; [email protected] 5 Section of Microbiology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy; [email protected] (M.S.); [email protected] (C.L.) * Correspondence: [email protected] (G.L.); [email protected] (C.D.A.); Tel.: +39-095-4781158 (G.L.); +39-095-4781170 (C.D.A.) These authors contributed equally to this work. y Received: 31 October 2019; Accepted: 14 December 2019; Published: 17 December 2019 Abstract: Pericytes are branched cells located in the wall of capillary blood vessels that are found throughout the body, embedded within the microvascular basement membrane and wrapping endothelial cells, with which they establish a strong physical contact.
    [Show full text]
  • Screening for Conn's Syndrome Primary Aldosteronism
    Clinical Laboratory - Biochemistry Screening for Conn's Syndrome (Primary Aldosteronism) 1.0 Background Primary aldosteronism is characterised biochemically by a low plasma renin with a raised plasma aldosterone. This guideline describes the recommended initial testing procedures when primary aldosteronism is suspected. Abnormal results do not necessarily confirm a diagnosis and should be referred for specialist opinion. 2.0 Indications Consider testing for primary aldosteronism when Hypertension and hypokalaemia (not diuretic-induced) Resistant hypertension Adrenal incidentaloma and hypertension Severe hypertension (SBP >160, DBP >100) 3.0 Patient Preparation It is best to take samples for renin and aldosterone estimation under standard conditions. The hormone measurements will not be made unless the following conditions are adhered to or have been modified after discussion - contact the Duty Biochemist. Discontinue spironolactone and amiloride at least 2 weeks before measurement. Other antihypertensive drugs can make interpretation difficult and ideally should also be discontinued. However – some useful information may be derived from testing in patients taking ACE inhibitors, diuretics, beta blockers and ARBs (see 6.0) Low serum potassium levels per se can inhibit aldosterone secretion, and ideally the serum potassium should be not less than 3.5 mmol/L at the time of analysis. Potassium supplements should be used to achieve this level, but these should be discontinued 12 hours before blood sampling. Ensure a normal diet with adequate sodium intake has been taken in the few days prior to sampling. 4.0 Procedure The patient should be seated for 30 minutes prior to blood sampling. A change in posture may cause a rise in aldosterone levels (false positive result), or a rise in renin levels (false negative).
    [Show full text]
  • Anatomy and Physiology of the Cardiovascular System
    Chapter © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC 5 NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION Anatomy© Jonesand & Physiology Bartlett Learning, LLC of © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION the Cardiovascular System © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION © Jones & Bartlett Learning, LLC © Jones & Bartlett Learning, LLC NOT FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION OUTLINE Aortic arch: The second section of the aorta; it branches into Introduction the brachiocephalic trunk, left common carotid artery, and The Heart left subclavian artery. Structures of the Heart Aortic valve: Located at the base of the aorta, the aortic Conduction System© Jones & Bartlett Learning, LLCvalve has three cusps and opens© Jonesto allow blood & Bartlett to leave the Learning, LLC Functions of the HeartNOT FOR SALE OR DISTRIBUTIONleft ventricle during contraction.NOT FOR SALE OR DISTRIBUTION The Blood Vessels and Circulation Arteries: Elastic vessels able to carry blood away from the Blood Vessels heart under high pressure. Blood Pressure Arterioles: Subdivisions of arteries; they are thinner and have Blood Circulation muscles that are innervated by the sympathetic nervous Summary© Jones & Bartlett Learning, LLC system. © Jones & Bartlett Learning, LLC Atria: The upper chambers of the heart; they receive blood CriticalNOT Thinking FOR SALE OR DISTRIBUTION NOT FOR SALE OR DISTRIBUTION Websites returning to the heart. Review Questions Atrioventricular node (AV node): A mass of specialized tissue located in the inferior interatrial septum beneath OBJECTIVES the endocardium; it provides the only normal conduction pathway between the atrial and ventricular syncytia.
    [Show full text]
  • Chapter 20 Lecture Outline
    Chapter 20 Lecture Outline See separate PowerPoint slides for all figures and tables pre- inserted into PowerPoint without notes. Copyright © McGraw-Hill Education. Permission required for reproduction or display. 1 Introduction • The route taken by blood was a point of much confusion for many centuries – Chinese emperor Huang Ti (2697–2597 BC) correctly believed that blood flowed in a circuit around the body and back to the heart – Roman physician Galen (129–c.199) thought blood flowed back and forth (like air in and out of lungs); he thought the liver created blood out of nutrients and organs consumed it – English physician William Harvey (1578–1657) performed experiments to show that the heart pumped blood and that it traveled in a circuit • Many of Harvey’s contemporaries rejected his ideas • After microscope was invented, capillaries were discovered by van Leeuwenhoek and Malpighi • Harvey’s work was the start of experimental physiology and it demonstrated how empirical science could overthrow dogma 20-2 General Anatomy of the Blood Vessels • Expected Learning Outcomes – Describe the structure of a blood vessel. – Describe the different types of arteries, capillaries, and veins. – Trace the general route usually taken by the blood from the heart and back again. – Describe some variations on this route. 20-3 General Anatomy of the Blood Vessels Copyright © The McGraw-Hill Education. Permission required for reproduction or display. Capillaries Artery: Tunica interna Tunica media Tunica externa Nerve Vein Figure 20.1a (a) © The McGraw-Hill
    [Show full text]
  • Nyctohemeral Rhythm of Plasma Renin Activity and Plasma Aldosterone in Children
    Pediatr. Res. 16: 354-356 (1982) Nyctohemeral Rhythm of Plasma Renin Activity and Plasma Aldosterone in Children M. DECHAUX,'25' M. BROYER, G. LENOIR, J. M. LIMAL, AND C. SACHS Deparfemenf de Physiologic, Groupe Hospitalier Necker Enfants Malades, Paris, France, [M. D., C. S.]; Diparfement de Nephrologie Pediafrique, Groupe Hospitalier Necker Enfants Malades, Paris, France [M. B., G. L.]; Service de Pediatric, C.H.R. d'Angers, Angers, France [J. M. L.] Summary them had any symptom or history of renal, cardiovascular, endo- crine, or ne;roiogic diseases. he^ had normal blood pressure. Circadian rhythms of plasma renin activity (PRA) and plasma Before the study, all drugs were discontinued for at least I month. aldosterone (PA) were studied in eight healthy children, 7 to 15 Standard diet meals were given at 8:00 AM, noon, and 6:30 PM. years old. Blood samples were obtained at 7MAM, 10:00 AM, 1: Blood samples (1.5 to 3 ml) were drawn through a small heparin- 00 PM, 400 PM, 500 PM, 8.00 PM, and midnight on day 1 and ized needle inserted in a forearm or an antecubital vein. Blood 400 AM and 7:00 AM on day 2. Children had normal activity samples for determination of PRA and PA were obtained at 7:00 during this test. AM on day 1, before breakfast, in the supine position. The Intra- and interindividual changes were noted in PRA in plasma children then got up and were active within the paediatric unit. taken in the upright position. Mean PRA values for samples taken Blood was taken in the upright position at 10:00 AM, 1:00 PM, 4: in the upright position were maximal at 1:00 PM (7 ng/ml/hr) and 00 PM, 5:00 PM, and 8:00 PM.
    [Show full text]